Atomoxetine Induced Seperation Anxiety: A Case Report

Atomoxetine Induced Seperation Anxiety: A Case Report

Atomoxetine, a selective norepinephrine (NE) inhibitor, is introduced as a safe non-stimulant alternative treatment of children and adolescents with attention deficit hyperactivity disorder (ADHD), especially co-morbid ADHD and anxiety disorder and/or Tourette syndrome. Generally known side effects...

Full description

Bibliographic Details
Main Authors:	Gonca Gul Celik, Aysegul Tahiroglu, Ayse Avci
Format:	Article
Language:	English
Published:	Cukurova University 2013-06-01
Series:	Çukurova Üniversitesi Tıp Fakültesi Dergisi
Subjects:	Atomoxetine ADHD Separation Anxiety
Online Access:	http://www.scopemed.org/fulltextpdf.php?mno=28092

Similar Items

Atomoksetin Tedavisine Bağlı Ayrılma Anksiyetesi: Bir Olgu Sunumu
by: Gonca Gül ÇELİK, et al.
Published: (2013-09-01)

Atomoxetine in the Treatment of the Most Common Comorbid Disorders of Attention-Deficit/Hyperactivity Disorder, Oppositional Defiant Disorder and Anxiety Disorders
by: Snircova E., et al.
Published: (2012-12-01)

Is atomoxetine effective in some comorbid mental disorders in ADHD?
by: Cesneková D., et al.
Published: (2016-09-01)

A critical appraisal of atomoxetine in the management of ADHD
by: Childress AC
Published: (2015-12-01)

Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
by: Joseph A, et al.
Published: (2016-03-01)

Treatment patterns, health care resource utilization, and costs in Japanese adults with attention-deficit hyperactivity disorder treated with atomoxetine
by: Imagawa H, et al.
Published: (2018-02-01)

Atomoxetine and Methylphenidate Treatment in ADHD
by: Snircova E., et al.
Published: (2015-05-01)

Pharmacogenetics and adhd treatment outcomes in the danish population-based IPSYCH sample
by: C. Lunenburg, et al.
Published: (2021-04-01)

Different effects of methylphenidate and atomoxetine on the behavior and brain transcriptome of zebrafish
by: Shiho Suzuki, et al.
Published: (2020-05-01)

Probable emergence of symptoms of trichotillomania by atomoxetine: a case report
by: Hamza Ayaydın
Published: (2019-04-01)

Psychogenic polydipsia case report use of additional clomipramine in atomoxetine (tur)
by: Berna Gündüz Çıtır, et al.
Published: (2020-11-01)

Atomoxetine associated red ear: A case report (eng)
by: Hande Ayraler Taner, et al.
Published: (2020-04-01)

Case report: Remission of chronic low back pain and oral dysesthesia comorbid with attention deficit/hyperactivity disorder by treatment with atomoxetine and pramipexole
by: Satoshi Kasahara, et al.
Published: (2023-06-01)

Effect of Atomoxetine on Behavioral Difficulties and Growth Development of Primary School Children with Attention-Deficit/Hyperactivity Disorder: A Prospective Study
by: Huiya Mei, et al.
Published: (2022-02-01)

Methylphenidate treatment in an analgesic dependent adolescent with ADHD (eng)
by: Ayşegül Yolga Tahiroğlu, et al.
Published: (2021-12-01)

Prescribing patterns for attention deficit hyperactivity disorder among children and adolescents in Taiwan from 2004 to 2017
by: Heng-Ching Liao, et al.
Published: (2023-06-01)

Lyophilized Nasal Inserts of Atomoxetine HCl Solid Lipid Nanoparticles for Brain Targeting as a Treatment of Attention-Deficit/Hyperactivity Disorder (ADHD): A Pharmacokinetics Study on Rats
by: Mahmoud H. Teaima, et al.
Published: (2023-02-01)

Effects of Atomoxetine for Cognitive Function in Methamphetamine-dependent Patients: A Randomized Controlled Trial
by: Ali Rabiey, et al.
Published: (2021-11-01)

Atomoxetine Induced Obsessive-Compulsive Disorder
by: Mengühan Araz Altay
Published: (2019-01-01)

Neuroprotective effects of atomoxetine against traumatic spinal cord injury in rats
by: Qing-Xian Hou, et al.
Published: (2016-03-01)

Anti-nociceptive effect of atomoxetine on paclitaxel-induced neuropathic pain in mice and role of alpha-2 adrenergic receptor
by: Azam Mesdaghinia, et al.
Published: (2022-04-01)

Attention deficit hyperactivity disorder - symptoms, diagnosis and therapy among children and adults.
by: Agata Surowiec, et al.
Published: (2023-08-01)

Off-label use of atomoxetine in adults: is it safe?
by: Peter Silverstone, et al.
Published: (2012-07-01)

Antihyperalgesic Activity of Atomoxetine on Diabetes-Induced Neuropathic Pain: Contribution of Noradrenergic and Dopaminergic Systems
by: Mustafa Burak Barbaros, et al.
Published: (2018-08-01)

Effectiveness and safety of atomoxetine for ADHD in population between 6 and 19 years: a systematic review
by: José Calleja, et al.
Published: (2012-09-01)

Atomoxetine induced hypomania in a patient with bipolar disorder and adult attention deficit hyperactivity disorder
by: Vijaya Kumar, et al.
Published: (2017-01-01)

Attention-deficit/hyperactivity disorder
by: A. M.E. du Plessis
Published: (2015-05-01)

The related factors with functionality and the comorbidity in the patients with adult seperation anxiety disorder (tur)
by: Mahmut Onur Karaytuğ, et al.
Published: (2021-12-01)

A novel spectrophotometric approach relies on a charge transfer complex between atomoxetine with quinone-based π-acceptor. Application to content uniformity test
by: Ahmed A. Abu-hassan
Published: (2023-04-01)

Atomoxetine might be more effective in improving sluggish cognitive tempo symptoms after switching from methylphenidate: A case report
by: Akın Tahıllıoğlu, et al.
Published: (2021-02-01)

Effectiveness of Psychostimulant and Non-Psychostimulant Drug Therapy in the Attention Deficit Hyperactivity Disorder
by: Adriana Cojocaru, et al.
Published: (2021-01-01)

Safety profiles of methylphenidate, amphetamine, and atomoxetine: analysis of spontaneous reports submitted to the food and drug administration adverse event reporting system
by: Wei Wei, et al.
Published: (2023-08-01)

Functional outcomes of extended-release methylphenidate and atomoxetine in children: retrospective chart analysis
by: Armagan Aral, et al.
Published: (2022-08-01)

Detection of atomoxetine and its metabolites in the urine by thin-layer chromatography and mass spectrometry
by: S. A. Karpushyna, et al.
Published: (2022-03-01)

Studying the association complex formation of atomoxetine and fluvoxamine with eosin Y and its application in their fluorimetric determination
by: Sayed M. Derayea, et al.
Published: (2018-01-01)

The effects of atomoxetine on weight, height, and body mass index in Turkish children and adolescents with attention deficit hyperactivity disorder
by: Serkan Turan, et al.
Published: (2019-10-01)

Quantitative prediction of the bitterness of atomoxetine hydrochloride and taste-masked using hydroxypropyl-β-cyclodextrin: A biosensor evaluation and interaction study
by: Shuying Li, et al.
Published: (2020-07-01)

Methylphenidate and atomoxetine prescribing trends in children in the Western Cape Province of South Africa, 2005–2013
by: Liezl Joubert, et al.
Published: (2018-07-01)

Cognitive Test Solution in Mice with Different Brain Weights after Atomoxetine
by: Olga V. Perepelkina, et al.
Published: (2023-05-01)

Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers
by: Silverstone Peter H, et al.
Published: (2012-03-01)